🇺🇸 Insulin glulisine, Insulin glargine in United States

Insulin glulisine, Insulin glargine (Insulin glulisine, Insulin glargine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Insulin glulisine, Insulin glargine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Insulin glulisine, Insulin glargine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Insulin glulisine, Insulin glargine in United States?

HaEmek Medical Center, Israel is the originator. The local marketing authorisation holder may differ — check the official source linked above.